These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7010378)

  • 1. Vaccine production technology.
    van Wezel AL
    Prog Clin Biol Res; 1980; 47():377-85. PubMed ID: 7010378
    [No Abstract]   [Full Text] [Related]  

  • 2. Innovative vaccine production technologies: the evolution and value of vaccine production technologies.
    Bae K; Choi J; Jang Y; Ahn S; Hur B
    Arch Pharm Res; 2009 Apr; 32(4):465-80. PubMed ID: 19407962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter from the Editor.
    Ellis R; Weiss A
    Hum Vaccin Immunother; 2015; 11(6):1297. PubMed ID: 26086583
    [No Abstract]   [Full Text] [Related]  

  • 4. Profile: Sinovac.
    Yang H
    Hum Vaccin Immunother; 2013 Dec; 9(12):2503-4. PubMed ID: 24322734
    [No Abstract]   [Full Text] [Related]  

  • 5. Matrix and backstage: cellular substrates for viral vaccines.
    Jordan I; Sandig V
    Viruses; 2014 Apr; 6(4):1672-700. PubMed ID: 24732259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The choice of the cell substrate for human virus vaccine production.
    Hayflick L
    Lab Pract; 1970 Jan; 19(1):58-62. PubMed ID: 4984599
    [No Abstract]   [Full Text] [Related]  

  • 7. [Principles for optimizing and gauging certain processes in vaccine production technology. V. Complex approach to gauging processes involved in assuring aseptic conditions in incubators].
    Matveev VE; Vorob'ev AA
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Oct; (10):17-23. PubMed ID: 7003993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a low-cost, insect larvae-derived recombinant subunit vaccine against RHDV.
    Pérez-Filgueira DM; Resino-Talaván P; Cubillos C; Angulo I; Barderas MG; Barcena J; Escribano JM
    Virology; 2007 Aug; 364(2):422-30. PubMed ID: 17434554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advantages of modern biotechnical developments for vaccine production in developing countries.
    Seifert HS; Böhnel H
    Dtsch Tierarztl Wochenschr; 1988; 95(7):266-8. PubMed ID: 3141123
    [No Abstract]   [Full Text] [Related]  

  • 10. Production of human virus vaccines in primary mammalian cells.
    Stones PB
    Lab Pract; 1970 Jan; 19(1):40-1 passim. PubMed ID: 4984598
    [No Abstract]   [Full Text] [Related]  

  • 11. Microbiological test for sanitation of equipment in the food factory.
    Herrera AG
    Methods Mol Biol; 2004; 268():303-10. PubMed ID: 15156040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of veterinary vaccines in the Sudan.
    Babiker SH
    Berl Munch Tierarztl Wochenschr; 1996 Jan; 109(1):8-9. PubMed ID: 8593158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA vaccines for biodefence.
    Garmory HS; Perkins SD; Phillpotts RJ; Titball RW
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1343-61. PubMed ID: 15935877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Problems of vaccine preparation].
    Lafontaine A
    Pathol Microbiol (Basel); 1969; 34(3):218-39. PubMed ID: 5379716
    [No Abstract]   [Full Text] [Related]  

  • 15. Global Programme for Vaccines and Immunization. Vaccine research and development.
    Wkly Epidemiol Rec; 1995 Nov; 70(45):318-9. PubMed ID: 8534594
    [No Abstract]   [Full Text] [Related]  

  • 16. Filovirus-like particles as vaccines and discovery tools.
    Warfield KL; Swenson DL; Demmin G; Bavari S
    Expert Rev Vaccines; 2005 Jun; 4(3):429-40. PubMed ID: 16026254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with viral antigens: infectious pancreatic necrosis.
    Christie KE
    Dev Biol Stand; 1997; 90():191-9. PubMed ID: 9270848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manipulation of immune responses via particle-mediated polynucleotide vaccines.
    Swain WF; Macklin MD; Neumann G; McCabe DE; Drape R; Fuller JT; Widera G; McGregor M; Callan RJ; Hinshaw V
    Behring Inst Mitt; 1997 Feb; (98):73-8. PubMed ID: 9382772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of viral antigens by enzyme-labeled antibody method].
    Hoshino M
    Rinsho Byori; 1971 Jun; 19(6):431-6. PubMed ID: 5169103
    [No Abstract]   [Full Text] [Related]  

  • 20. Strategies for the development of vaccines conferring broad-spectrum protection.
    Nagy G; Emody L; Pál T
    Int J Med Microbiol; 2008 Jul; 298(5-6):379-95. PubMed ID: 18485818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.